We have set science-based targets and are actively working towards net-zero operations 2050.

Our direct emissions (Scope 1&2) include company facilities and vehicles, and purchased electricity, steam, heating, and cooling for own use. Our science-based target 2030 is to reduce these emissions by 79%, compared to 2019 base year. To meet this target, we will continue to improve energy efficiency in our main facilities, purchase electricity from renewable energy sources, and shift to electric leased cars.

We are reducing the environmental impact in our supply chain.

Embla Medical operates in 36 countries and the emissions from our value chain constitute 91% of our total base year emissions, with the biggest impact from our purchased goods and services, mainly our purchased raw materials, components, and finished goods. Our near-term Scope 3 science-based target is to reduce absolute emissions by 25% by 2030, compared to 2021 base year. The target includes purchased goods and services, fuel- and energy-related activities, and both upstream and downstream transportation and distribution. We fully recognize and acknowledge the challenge to meet our Scope 3 science-based target as it means rethinking how we design, manufacture, and sell our products and services. The task is to decouple our growth from our emissions.

We are reducing the environmental impact of our products and services.

At Embla Medical, sustainability is shaping the way we innovate. A significant part of the environmental impact of a product is determined during the design stage. Eco-Design solutions with reduced environmental impact are key to reaching our science-based emissions reduction targets. We are establishing and executing carbon footprint reduction plans to address new and existing products, services, and packaging.